Bavachinin is primarily studied for its anti-inflammatory and anti-cancer properties. It has shown potential in inhibiting the growth of various cancer cells, particularly in liver and breast cancer models, by inducing apoptosis and suppressing cell proliferation. The compound also exhibits significant anti-diabetic effects by activating the PPARγ pathway, which helps improve insulin sensitivity and glucose uptake. Additionally, bavachinin demonstrates neuroprotective activity, making it a candidate for research in neurodegenerative diseases like Alzheimer’s. Its ability to modulate key signaling pathways involved in metabolism and inflammation supports its use in developing therapeutics for metabolic disorders and chronic inflammatory conditions.